Investor Relations

A Vertically Integrated Medical Cannabis Company

Columbia Care is a vertically integrated medical cannabis company with a U.S. license portfolio* that allows for up to 730K square feet of cultivation and the potential to produce more than 125 K kilograms of dried flower per year.

TGS Acquisition

View Presentation

Columbia Care Receives Approval to Trade on the Canadian Securities Exchange (CSE)

View Press Release View All

Mar 23, 2020 • 9:14 AM EDT

Columbia Care Provides Operational Update

Mar 19, 2020 • 5:50 PM EDT

Columbia Care Sets Weekly Revenue Records in Eight States; Issues Preliminary Results & Opens Insider Trading Window

Mar 10, 2020 • 7:30 AM EDT

Columbia Care Reports Fourth Quarter and Full Year 2019 Financial Results

Investor Presentation

View Presentation

May 12, 2020

Canaccord Genuity’s 4th Annual Global Cannabis Conference

View All

Mar 15 – Mar 17, 2020

32nd Annual ROTH Conference

Mar 10, 2020

Needham Cannabis Multi-State Operator Conference

View All

Stock Snapshot

Columbia Care at a Glance

Licenses in 17 jurisdictions across
U.S. and E.U.
(includes industrial hemp cultivation)

Facilities that are operational or in development.

>1.6M

Sales transactions to date

As of March 2020 • ColCare Mgt Presentation

Setting the Standard for Compassion and Quality

Columbia Care Inc. (“Columbia Care” or the “Company”) is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU. With over 1.6 million successful sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.

View Management Team View Board of Directors

Pharmaceutical Quality Products

Our balanced portfolio of proprietary, precisely-formulated and precision dosed pharmaceutical-quality medical, health, wellness and consumer branded products include hard-pressed tablets, vapes, tinctures, suppositories and topicals to address the needs of every market.

Research and Development

In order to further our strategic insight and innovation, we develop strategic relationships with clinical and scientific organizations (such as Mount Sinai Hospital), agricultural and manufacturing organizations (such as the Pennsylvania Department of Agriculture), and organizations with a technological advantage (such as Arizona State University).

IR Contacts

Company

Columbia Care Inc.
745 5th Avenue
Suite 1701
New York, NY 10151
T: 212-634-7100
info@col-care.com